AdamsonE.: Isoenzyme transitions of creatine phosphokinase. Aldolase and phosphoglycerate mutase in differentiating mouse cells. J. Embryol. Exptl. Morphol., 35; 355–367 (1976).
2.
De LucaM., HallN., RiceR., KaplanN.: Creatine kinase isozymes in human tumors. Biochem. Biophys. Res. Comm., 99; 189–195 (1981).
3.
FeldR. D., Van SteirteghemA. C., ZweigM. H., WeimarG. W., NarayanaA. S., WitteD. L.: The presence of creatine kinase BB isoenzyme in patients with prostatic cancer. Clin. Chim. Acta, 100; 267–273 (1980).
4.
LevineA. J., TorosianM., SarokhanA. J., TereskyA. K.: Biochemical criteria for the in vitro differentiation of embryoid bodies produced by a transplantable teratoma of mice. The production of acetylcholine esterase and creatine phosphokinase by teratoma cell. J. Cellular Physiol., 84; 311–318 (1974).
5.
OmennG. S., HermodsonM. A.: Human phosphoglycerate mutase: Isozyme marker for muscle differentiation and for neoplasia. In: MarkertC. L. (ed.): Developmental biology. New York Academic Press Inc. (1975).
6.
PerrymanM. B., StraussA. W., BuettnerT. L., RobertsR.: Molecular heterogeneity of creatine kinase isoenzymes. Biochim. Biophys. Acta, 747; 284–290 (1983).
7.
RonaE., NagyA., WollemannM., SlowickF.: Localisation of various isoenzymes in different cell fractions of brain tumors. Neuropathol. Polska, 10; 207–220 (1972).
8.
SchapiraF.: Isozymes and cancer. Advan. Cancer Res., 18; 77–4153 (1973).
9.
SchapiraF., MichaenC., JunienC.: Foetal enzyme pattern of two alveolar rhabdomyosarcomas. Rev. Européenne Études Clin. Biol., 17; 896–899 (1972).
10.
ShattonJ. B., MorrisH. P., WeinhouseS.: Creatine kinase activity and isozymes composition in normal tissues and neoplasms of rats and mice. Cancer Res., 39; 492–501 (1979).
